ArticleFrontiers in pharmacology2019

Loxapine for Treatment of Patients With Refractory, Chemotherapy-Induced Neuropathic Pain: A Prematurely Terminated Pilot Study Showing Efficacy But Limited Tolerability.

Sven Schmiedl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.